Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7690)
All Articles published online
|
Publishing Process of This Article
|
Nov 6, 2017 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Papaconstantinou I, Kapizioni C, Legaki E, Xourgia E, Karamanolis G, Gklavas A, Gazouli M. Association of miR-146 rs2910164, miR-196a rs11614913, miR-221 rs113054794 and miR-224 rs188519172 polymorphisms with anti-TNF treatment response in a Greek population with Crohn’s disease. World J Gastrointest Pharmacol Ther 2017; 8(4): 193-200 [PMID: PMC5680166 DOI: 10.4292/wjgpt.v8.i4.193] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v8/i4/193.htm |
| Number | Citing Articles |
| 1 |
Manoj Kumar, Selvasankar Murugesan, Nazira Ibrahim, Mamoun Elawad, Souhaila Al Khodor. Predictive biomarkers for anti-TNF alpha therapy in IBD patients. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05058-1
|
| 2 |
Louis Berthet, Maite Casado-Bedmar, Émilie Viennois. Rôle des miARN dans les maladies inflammatoires chroniques de l’intestin et potentiel diagnostique et thérapeutique. Bulletin de l'Académie Nationale de Médecine 2024; 208(8): 999 doi: 10.1016/j.banm.2024.03.013
|
| 3 |
Laurence Don Wai Luu, Georgia Popple, Samuel Pok Wei Tsang, Karla Vinasco, Ida Hilmi, Ruey Terng Ng, Kee Seang Chew, Shin Yee Wong, Stephen Riordan, Way Seah Lee, Hazel M Mitchell, Nadeem O Kaakoush, Natalia Castaño‐Rodríguez. Genetic variants involved in innate immunity modulate the risk of inflammatory bowel diseases in an understudied Malaysian population. Journal of Gastroenterology and Hepatology 2022; 37(2): 342 doi: 10.1111/jgh.15752
|
| 4 |
Paraskevi Nani, Melpomeni Ladopoulou, Evgenia H. Papaioannou, Evangelia D. Papagianni, Charalabos Antonatos, Panagiotis Xiropotamos, Andreas Kapsoritakis, Petros S. Potamianos, Konstantinos Karmiris, Charalambos Tzathas, Aikaterini Patsatsi, Elisavet Lazaridou, Efterpi Zafiriou, Angeliki Roussaki-Schulze, Sophia Georgiou, Katerina Grafanaki, Georgios K. Georgakilas, Yiannis Vasilopoulos. Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn’s Disease and Psoriasis. Genes 2023; 14(2): 445 doi: 10.3390/genes14020445
|
| 5 |
Jing Li, Hua Hong. Oxymatrine-induced Apoptosis in Fibroblasts like Synoviocytes via Regulation
of miR-146a/ TRAF6/JNK1 Axis in Rheumatoid Arthritis. Letters in Drug Design & Discovery 2023; 20(2): 232 doi: 10.2174/1570180819666220530143250
|
| 6 |
Olga Brusnic, Adrian Boicean, Sorin-Radu Fleacă, Blanca Grama, Florin Sofonea, Corina Roman-Filip, Iulian Roman-Filip, Adelaida Solomon, Sabrina Bîrsan, Horatiu Dura, Corina Porr, Cristian Adrian, Danusia Onisor. Importance of Fecal Microbiota Transplantation and Molecular Regulation as Therapeutic Strategies in Inflammatory Bowel Diseases. Nutrients 2024; 16(24): 4411 doi: 10.3390/nu16244411
|
| 7 |
Andrea Padoan, Mario Plebani, Daniela Basso. Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity. International Journal of Molecular Sciences 2019; 20(3): 676 doi: 10.3390/ijms20030676
|
| 8 |
Fan Yang, Xiao-Fang Li, Li-Na Cheng, Xiu-Ling Li. Long non-coding RNA CRNDE promotes cell apoptosis by suppressing miR-495 in inflammatory bowel disease. Experimental Cell Research 2019; 382(2): 111484 doi: 10.1016/j.yexcr.2019.06.029
|
| 9 |
Guanglin Cui, Qingbo Fan, Zhenfeng Li, Rasmus Goll, Jon Florholmen. Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. eBioMedicine 2021; 66: 103329 doi: 10.1016/j.ebiom.2021.103329
|
| 10 |
Milena Peruhova, Daniela Stoyanova, Dimitrina Georgieva Miteva, Meglena Kitanova, Milko Bozhidarov Mirchev, Tsvetelina Velikova. Genetic factors that predict response and failure of biologic therapy in inflammatory bowel disease. World Journal of Experimental Medicine 2025; 15(1): 97404 doi: 10.5493/wjem.v15.i1.97404
|
| 11 |
Eleni Xourgia, Athanasia Papazafiropoulou, Andreas Melidonis. Circulating microRNAs as biomarkers for diabetic neuropathy: A novel approach. World Journal of Experimental Medicine 2018; 8(3): 18-23 doi: 10.5493/wjem.v8.i3.18
|
| 12 |
Mitchell R. K. L. Lie, Emma Paulides, C. Janneke van der Woude. Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events. International Journal of Colorectal Disease 2020; 35(8): 1489 doi: 10.1007/s00384-020-03663-2
|
| 13 |
Pierluigi Puca, Ivan Capobianco, Gaetano Coppola, Federica Di Vincenzo, Valentina Trapani, Valentina Petito, Lucrezia Laterza, Daniela Pugliese, Loris Riccardo Lopetuso, Franco Scaldaferri. Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease. International Journal of Molecular Sciences 2024; 25(5): 2789 doi: 10.3390/ijms25052789
|
| 14 |
Boris Gole, Uroš Potočnik. Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn’s Disease—A Systematic Review and Gene Ontology Analysis. Cells 2019; 8(6): 515 doi: 10.3390/cells8060515
|